IDEXX Laboratories Stock Surges on Strong Q4 Earnings and Revenue
IDEXX stock surged 10% after exceeding Q4 earnings and revenue expectations, driven by strong demand for animal testing products. The company projects continued growth in 2024 and will launch a new canine lymphoma test.
IDEXX Laboratories Stock Surges on Strong Q4 Earnings and Revenue Read More »